Dr. Andrea Smiens O'Shea, MD

Dr. O'Shea practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. O'Shea's NPI, 1588922488, was assigned on April 27, 2012. Dr. O'Shea holds Minnesota license 65179.

Dr. O'Shea's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. O'Shea's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. O'Shea is also affiliated with Methodist Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. O'Shea to 3 more hospitals, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Shea practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. O'Shea's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. O'Shea's licenses on file in 2 states: Minnesota and Wisconsin.

CMS data shows 32 Medicare services from Dr. O'Shea across 1 procedure code in 2024, all of them office visits, for 56 Medicare patients. Medicare paid $1,503 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Dr. O'Shea in 2024. The largest group is 65 to 74, with 33 patients. 68% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. O'Shea's median patient age at 65, with 97% women.

In 2024, Dr. O'Shea wrote 221 Medicare Part D claims for 57 patients. 89% of them were for generic drugs. CMS names the drug for 130 of them, across 8 drugs with 11 or more claims each, at $197,492 in total drug cost. In 2023, CMS named 130 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. O'Shea for performance year 2024, reported as part of a group. Dr. O'Shea accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. O'Shea as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. O'Shea, published from 2018 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms, Cell Line, Tumor and Chemotherapy, Adjuvant. Dr. O'Shea has published most often in Gynecol Oncol. Dr. O'Shea's most frequent co-authors are Lisa M. Barroilhet, MD, Kevin William McCool, MD and Peter Alexander Argenta, MD.

CMS Open Payments shows 2 general payments to Dr. O'Shea from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $24.